Tengjun Biotechnology Corp. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 0.453112 million compared to net income of USD 3.92 million a year ago.
For the six months, sales was USD 8.52 million compared to USD 55.57 million a year ago. Net loss was USD 0.090445 million compared to net income of USD 4.14 million a year ago.